ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - RUBIUS THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 92 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$372,000
+30.1%
49,000
-14.2%
0.00%–
Q3 2020$286,000
-13.1%
57,087
+3.9%
0.00%
-100.0%
Q2 2020$329,000–54,959–0.00%–
 Download
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders